SCHEMBL30690676

SCHEMBL30690676

COC[C@H]1CCCN1CC(=O)Nc1cnc(F)c(NC(=O)c2cnc3[nH]c(-c4cnn(C)c4)cc3c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.38
DYRK1A Q13627 4/20 0.38
WNT1 P04628 3/20 0.38
CCNA2 P20248 2/20 0.36
CDK2 P24941 2/20 0.36
TTK P33981 2/20 0.36
KIT P10721 4/20 0.35
ABL1 P00519 1/20 0.35
CYP3A4 P08684 1/20 0.35
ABCB1 P08183 2/20 0.35
CSF1R P07333 2/20 0.34
AURKA O14965 3/20 0.34
CLK2 P49760 1/20 0.34
CLK3 P49761 1/20 0.34
MCHR2 Q969V1 1/20 0.33
MCHR1 Q99705 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
MAP4K1 Q92918 1/20 0.33
TLR9 Q9NR96 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690431 1.00 GSK3B (0.38) GSK3BDYRK1AWNT1CCNA2CDK2
SCHEMBL30690695 0.90 GSK3B (0.48) GSK3BDYRK1AWNT1KITABL1
SCHEMBL30690562 0.85 GSK3B (0.45) GSK3BDYRK1AWNT1CCNA2CDK2
SCHEMBL30690662 0.85 GSK3B (0.45) GSK3BDYRK1AWNT1CCNA2CDK2
SCHEMBL30690612 0.84 GSK3B (0.47) GSK3BDYRK1AWNT1KITABL1
SCHEMBL30690703 0.82 GSK3B (0.50) GSK3BDYRK1AWNT1KITABL1
SCHEMBL30690548 0.82 GSK3B (0.49) GSK3BDYRK1AWNT1KITABL1
SCHEMBL30690664 0.82 GSK3B (0.49) GSK3BDYRK1AWNT1KITABL1
SCHEMBL30690674 0.82 ALDH1A1 (0.42) GSK3BDYRK1AWNT1CCNA2CDK2
SCHEMBL30690544 0.82 GSK3B (0.46) GSK3BDYRK1AWNT1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247593-A1 PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO claimed